Chemical activators of LOC100134934 can be understood through their interactions with various cellular pathways that lead to the protein's activation. Forskolin directly targets adenylyl cyclase, thereby increasing the intracellular levels of cyclic AMP (cAMP). This surge in cAMP levels results in the activation of protein kinase A (PKA), which is known to phosphorylate target proteins within the cell, including LOC100134934, thereby activating it. Similarly, IBMX works by inhibiting phosphodiesterases, which normally break down cAMP. Its action results in an accumulation of cAMP within the cell, again leading to activation of PKA and subsequent phosphorylation and activation of LOC100134934. Another activator, Phorbol 12-myristate 13-acetate (PMA), acts upon protein kinase C (PKC), a kinase that phosphorylates a variety of proteins. PKC, once activated, can phosphorylate LOC100134934, leading to its activation.
The action of Ionomycin increases intracellular calcium levels, which activates calcium-dependent protein kinases capable of phosphorylating LOC100134934. Meanwhile, Okadaic Acid and Calyculin A both inhibit protein phosphatases like PP1 and PP2A, leading to a net increase in protein phosphorylation by kinases, which includes the activation of LOC100134934. Anisomycin activates stress-activated protein kinases, which in response to cellular stress might phosphorylate and activate LOC100134934. Thapsigargin, by disrupting calcium homeostasis, can indirectly lead to the activation of kinases that phosphorylate LOC100134934. Bisindolylmaleimide I, while primarily a PKC inhibitor, can cause compensatory activation of other kinases, which could lead to the activation of LOC100134934. Dibutyryl-cAMP, a cAMP analog, activates PKA, resulting in the phosphorylation and activation of LOC100134934. A23187, also known as Calcimycin, acts as a calcium ionophore that increases intracellular calcium, activating kinases that can phosphorylate and activate LOC100134934. Lastly, 1,2-Dioctanoyl-sn-glycerol, a DAG analog, activates PKC, which could then phosphorylate and activate LOC100134934 as part of the signal transduction processes. Each of these chemicals, through their influence on specific pathways and kinases, activate LOC100134934 by ensuring it is phosphorylated, which is a common regulatory mechanism for protein activation.
関連項目
Items 1 to 10 of 12 total
画面:
| 製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
アデニルシクラーゼを直接活性化し、cAMPレベルを上昇させ、PKAを活性化する。PKAはcAMP依存性シグナル伝達経路の一部としてLOC100134934をリン酸化し、活性化する。 | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
ホスホジエステラーゼを阻害し、細胞内のcAMPレベルを上昇させる。上昇したcAMPはPKAを活性化し、PKAはLOC100134934をリン酸化して活性化する可能性がある。 | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PKCシグナル伝達経路の一部として、LOC100134934を含む可能性のある標的タンパク質をリン酸化することが知られているPKCを活性化する。 | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
細胞内カルシウム濃度を上昇させ、カルシウム依存性プロテインキナーゼを活性化し、LOC100134934をリン酸化して活性化する。 | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
タンパク質リン酸化酵素PP1およびPP2Aを阻害し、LOC100134934の活性化につながるキナーゼによるリン酸化を増加させます。 | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000C | 10 µg 100 µg 1 mg | $160.00 $750.00 $3000.00 | 59 | |
岡田酸と同様に、リン酸化酵素を阻害し、キナーゼによるLOC100134934のリン酸化と活性化を増加させる。 | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
ストレス活性化プロテインキナーゼを活性化し、細胞ストレスに対する応答の一部としてLOC100134934をリン酸化し活性化する可能性がある。 | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
カルシウムのホメオスタシスを破壊し、LOC100134934をリン酸化して活性化するキナーゼの活性化を引き起こす。 | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
PKC阻害剤ではあるが、LOC100134934を活性化する可能性のある他のキナーゼの代償的活性化を引き起こす可能性がある。 | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
PKAを活性化するcAMPアナログで、PKAはその後LOC100134934をリン酸化し活性化する。 | ||||||